[1] GHODKE-PURANIK Y, THORN C F, LAMBA J K, et al. Valproic acid pathway: pharmacokinetics and pharmacodynamics[J]. Pharmacogenet Genomics,2013,23(4):236-241. doi:  10.1097/FPC.0b013e32835ea0b2
[2] 应义, 崔虓, 张慧. 抗癫痫药物研究现状与新进展[J]. 中国药业, 2012, 21(20):110-112. doi:  10.3969/j.issn.1006-4931.2012.20.068
[3] 王灿, 马虹英, 王方杰, 等. 丙戊酸肝毒性的早期预警及预防研究状况[J]. 中国临床药理学杂志, 2015, 31(2):150-154.
[4] SCHMID M M, FREUDENMANN R W, KELLER F, et al. Non-fatal and fatal liver failure associated with valproic acid[J]. Pharmacopsychiatry,2013,46(2):63-68.
[5] 陈玲, 苗苗, 刘俊. 癫痫患者丙戊酸血清浓度监测及与临床疗效的关联性分析[J]. 中国医院用药评价与分析, 2015, 15(12):1613-1616.
[6] WANG W Z, WU J Z, LI S C, et al. Sodium valproate for epilepsy in rural China: an efficacy and safety assessment in primary care[J]. Epilepsy Res,2012,102(3):201-205. doi:  10.1016/j.eplepsyres.2012.06.004
[7] SURENDRADOSS J, CHANG T K, ABBOTT F S. Assessment of the role of in situ generated(E)-2, 4-diene-valproic acid in the toxicity of valproic acid and(E)-2-ene-valproic acid in sandwich-cultured rat hepatocytes[J]. Toxicol Appl Pharmacol,2012,264(3):413-422. doi:  10.1016/j.taap.2012.08.018
[8] 储小曼, 郭岑, 张丽芳. 丙戊酸的代谢特征与肝毒性的相关性[J]. 中国医院药学杂志, 2013, 33(19):1611-1614.
[9] 谢新芳, 温燕, 高守红, 等. 丙戊酸钠及其代谢产物的体外肝毒性研究[J]. 药学实践杂志, 2017, 35(1):43-47, 53. doi:  10.3969/j.issn.1006-0111.2017.01.011
[10] GAO S H, MIAO H J, TAO X, et al. LC-MS/MS method for simultaneous determination of valproic acid and major metabolites in human plasma[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2011,879(21):1939-1944. doi:  10.1016/j.jchromb.2011.05.022